Hypertrophic Cardiomyopathy.

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Hypertrophic cardiomyopathy (HCM) exhibits a wide spectrum of clinical severity, from asymptomatic to severe disease.
• Medical therapy is effective for mild to moderate HCM but offers limited benefit and potential complications in severe cases.
• Symptomatic patients with outflow tract gradients may initially benefit from pacing, but long-term efficacy is often limited by disease progression.

Purpose of the Study:

• To review the clinical presentation and management strategies for hypertrophic cardiomyopathy (HCM).
• To discuss the efficacy and limitations of various treatment modalities, including medical therapy, pacing, surgery, and transplantation.
• To provide guidance on selecting appropriate interventions based on disease severity and patient factors.

Main Methods:

• Review of existing literature on hypertrophic cardiomyopathy (HCM) management.
• Analysis of treatment outcomes for medical, interventional, and surgical approaches.
• Discussion of prognostic indicators and criteria for advanced therapies.

Main Results:

• Medical therapy is beneficial for mild/moderate HCM but less effective and potentially complicating for severe disease.
• Atrioventricular sequential pacing can alleviate symptoms in some patients with obstructive HCM, but benefits are often temporary.
• Surgical myotomy-myectomy outcomes are surgeon-dependent, while cardiac transplantation is a consideration for end-stage disease.

Conclusions:

• Treatment decisions for hypertrophic cardiomyopathy (HCM) must be individualized based on clinical presentation and disease severity.
• While medical therapy and pacing offer symptomatic relief, advanced or end-stage HCM may necessitate surgical intervention or cardiac transplantation.
• Early consideration of cardiac transplantation in severe HCM with left ventricular dysfunction is crucial for improved outcomes.